TNPSC Thervupettagam

mNexspike Vaccine

June 6 , 2025 7 hrs 0 min 19 0
  • The US approved a new COVID-19 vaccine mNexspike, made by Moderna.
  • The new vaccine is a step toward next-generation coronavirus vaccines.
  • It allows for a lower dose a fifth of the dose of its current Covid-19 vaccine.
  • It is particularly aimed at individuals aged 65 and older and those aged 12 to 64.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories